HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 15.82
Day range
kr 15.30 - kr 15.98
Year range
kr 14.64 - kr 34.20
Market cap
55.50M SEK
Avg Volume
18.46K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.30M | 36.06% |
Operating expense | 11.21M | -17.69% |
Net income | -8.44M | 19.26% |
Net profit margin | -367.49 | 40.66% |
Earnings per share | — | — |
EBITDA | -9.40M | 26.07% |
Effective tax rate | 13.52% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.88M | -51.73% |
Total assets | 61.76M | -40.90% |
Total liabilities | 28.47M | -19.05% |
Total equity | 33.29M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.26 | — |
Return on assets | -36.03% | — |
Return on capital | -61.69% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.44M | 19.26% |
Cash from operations | -10.46M | 37.48% |
Cash from investing | — | — |
Cash from financing | -147.00K | -100.58% |
Net change in cash | -11.89M | -251.35% |
Free cash flow | -8.68M | 40.99% |
About
Founded
2015
Website
Employees
20
